🚀 @OncoPanCure's FFF Investment Round is NOW OPEN! Help us advance OPC080, our innovative drug candidate for pancreatic cancer. 📅 Nov 18, 2026 | 19:00 CET 📍 IQS Barcelona + Online Join our investor presentation! 👉 lnkd.in/eUxrtwYi #OncoPanCure #PancreaticCancer

A major milestone for @OncoPanCure We are proud to announce the licensing agreement with @IQSbarcelona School of Engineering and @Xenopat_ for OPC080, our lead candidate for pancreatic cancer From academic discovery to therapeutic development #OPC080 #PancreaticCancer #Biotech

OncoPanCure was founded in July 2026 as a spin-off from IQS School of Engineering (Universitat Ramon Llull) and Xenopat S.L. to advance OPC080, a novel therapeutic candidate currently in preclinical development. https.//www.oncopancure.com